Your browser doesn't support javascript.
loading
Paresthesia-Free Spinal Nerve Root Stimulation for the Treatment of Chronic Neuropathic Pain.
Abbass, Mohamad; Santyr, Brendan G; Parrent, Andrew G; MacDougall, Keith W; Staudt, Michael D.
Afiliação
  • Abbass M; Department of Clinical Neurological Sciences, London Health Sciences Centre, Western University, London, ON, Canada.
  • Santyr BG; Department of Clinical Neurological Sciences, London Health Sciences Centre, Western University, London, ON, Canada.
  • Parrent AG; Department of Clinical Neurological Sciences, London Health Sciences Centre, Western University, London, ON, Canada.
  • MacDougall KW; Department of Clinical Neurological Sciences, London Health Sciences Centre, Western University, London, ON, Canada.
  • Staudt MD; Department of Clinical Neurological Sciences, London Health Sciences Centre, Western University, London, ON, Canada.
Neuromodulation ; 23(6): 831-837, 2020 Aug.
Article em En | MEDLINE | ID: mdl-32725757
ABSTRACT

OBJECTIVE:

Stimulation of the dorsal spinal roots, or spinal nerve root stimulation (SNRS), is a neuromodulation modality that can target pain within specific dermatomal distributions. The use of paresthesia-free stimulation has been described with conventional dorsal column spinal cord stimulation, although has yet to be described for SNRS. This objective of this study was to investigate the efficacy of paresthesia-free high-frequency (1000-1200 Hz) SNRS in the treatment of intractable, dermatomal neuropathic pain. MATERIALS AND

METHODS:

A retrospective chart review was performed on 14 patients implanted with SNRS in varying distributions Ten patients initially received tonic stimulation and crossed over to a paresthesia-free paradigm and four patients received only paresthesia-free stimulation. The primary outcome was reduction in pain severity (visual analog scale [VAS]), measured at baseline and follow-up to 24 months with paresthesia-free stimulation.

RESULTS:

All 14 patients who received paresthesia-free stimulation had significant improvement in pain severity at a mean follow-up of 1.39 ± 0.15 years (VAS 7.46 at baseline vs. 3.25 at most recent follow-up, p < 0.001). Ten patients were initially treated with tonic stimulation and crossed over to paresthesia-free stimulation after a mean of 61.7 months. Baseline pain in these crossover patients was significantly improved at last follow-up with tonic stimulation (VAS 7.65 at baseline vs. 2.83 at 48 months, p < 0.001), although all patients developed uncomfortable paresthesias. There was no significant difference in pain severity between patients receiving tonic and paresthesia-free stimulation.

CONCLUSIONS:

We present real-world outcomes of patients with intractable dermatomal neuropathic pain treated with paresthesia-free, high-frequency SNRS. We demonstrate its effectiveness in providing pain reduction at a level comparable to tonic SNRS up to 24 months follow-up, without producing uncomfortable paresthesias.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Parestesia / Raízes Nervosas Espinhais / Dor Crônica / Estimulação da Medula Espinal / Neuralgia Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Neuromodulation Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Parestesia / Raízes Nervosas Espinhais / Dor Crônica / Estimulação da Medula Espinal / Neuralgia Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Neuromodulation Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Canadá